Premium
Boceprevir dosing for late responders and null responders: The role of bridging data between treatment‐naïve and ‐experienced subjects
Author(s) -
Florian Jeffry,
Jadhav Pravin R.,
Amur Shashi,
Ayala Ruben,
Harrington Patrick,
Mishra Poonam,
O'Rear Jules,
Pacanowski Michael,
Robertson Sarah,
Singer Mary,
Soon Greg,
Zeng Wen,
Murray Jeffrey
Publication year - 2013
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.25843
Subject(s) - boceprevir , telaprevir , medicine , dosing , ribavirin , regimen , hepatitis c virus , pharmacology , gastroenterology , immunology , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom